Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women

NCT02400567 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Neoadjuvant Operable Breast Cancer

Interventions

DRUG: Fluorouracile
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: Letrozole
DRUG: Palbociclib

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]